Singapore’s A*star wants to use micro-carrier tech to capture a share of the global stem cell manufacturing market. Demand for stem cells has increased markedly in recent years, creating a significant opportunity for those willing to innovate to help industry address its manufacturing challenges according to Steve Oh from A*star. “In a bid to do that, the Singapore government invested $80 million in three programmes to manufacture living cells as medicines,” Oh told delegates at the Cell and Gene Therapy…